Extended Use of Central Veno-Arterial Extracorporeal Membrane Oxygenation in Lung Transplantation for Patients with Pulmonary Arterial Hypertension
European Journal of Cardio-Thoracic Surgery · 02.08.2025 · 67 (8)
DOI: 10.1093/ejcts/ezaf256 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Cardio-Thoracic Surgery, online erschienen am 04.08.2025. Verfasst von Mitsuaki Kawashima und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, The University of Tokyo Hospital, Tokyo 113-8655, Japan. Hauptthemen laut MEDLINE: Extracorporeal Membrane Oxygenation, Lung Transplantation, Pulmonary Arterial Hypertension. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objectives
Lung transplantation (LTx) for patients with pulmonary arterial hypertension (PAH) is associated with high postoperative morbidity and mortality. Extracorporeal membrane oxygenation (ECMO) supports patients’ haemodynamics during and after LTx. However, the optimal ECMO strategy, especially for patients with PAH, is debated. Here, we report our unique strategy for patients with PAH, using postoperative central veno-arterial (VA)-ECMO combined with delayed chest closure.
Methods
This was a retrospective single-centre study of consecutive bilateral lung transplantations for adult patients with PAH performed between 2021 and 2024. Patients’ characteristics, perioperative ECMO strategy, and postoperative outcomes were reviewed.
Results
During the study period, 20 PAH patients (idiopathic or hereditary PAH [n = 17], PAH secondary to collagen disease [n = 1], pulmonary veno-occlusive disease [n = 1], and Eisenmenger syndrome [n = 1]) underwent cadaveric LTx. Intraoperative support comprised either central VA-ECMO (n = 17) or cardiopulmonary bypass (n = 3). In 17 patients, central VA-ECMO was maintained postoperatively with temporary skin closure. The reason for postoperative central VA-ECMO was anticipated post-LTx heart failure due to PAH and suboptimal cardiac function. The median duration of ECMO support was 4 days (interquartile range: 2-4). There were 9 (45.0%) haemothorax evacuations while patients were on postoperative central VA-ECMO. No patients experienced haemodynamic collapse after LTx. All patients survived during the observation period, resulting in a 100% survival rate at both 90 days and 1 year (95% confidence interval: 83.2%-100%).
Conclusions
Extended postoperative central VA-ECMO and delayed chest closure were feasible for patients with PAH who underwent LTx. Meticulous haemostasis is mandatory, given the high chance of haemothorax evacuation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Thoracic Surgery, The University of Tokyo Hospital, Tokyo 113-8655, Japan.
- Organ Transplantation Center, The University of Tokyo Hospital, Tokyo 113-8655, Japan.
- Department of Clinical Engineering, The University of Tokyo Hospital, Tokyo 113-8655, Japan.
- Department of Anesthesiology and Pain Relief Center, The University of Tokyo Hospital, Tokyo 113-8655, Japan.
- Department of Cardiovascular Surgery, The University of Tokyo Hospital, Tokyo 113-8655, Japan.
ORCID-Profile: Mitsuaki Kawashima, Naohiro Ijiri, Chihiro Konoeda, Gouji Toyokawa, Keita Nakao, Yue Cong, Haruaki Hino, Koichi Kashiwa, Michiko Ushio, Masahiko Ando, Shogo Shimada, Minoru Ono, Masaaki Sato
Zitieren
APA
Kawashima, M., Ijiri, N., Konoeda, C., Toyokawa, G., Nakao, K., Cong, Y., Hino, H., Kurosawa, H., Kashiwa, K., Ushio, M., Kawamura, G., Ando, M., Shimada, S., Ono, M., & Sato, M. (2025). Extended Use of Central Veno-Arterial Extracorporeal Membrane Oxygenation in Lung Transplantation for Patients with Pulmonary Arterial Hypertension. European Journal of Cardio-Thoracic Surgery, 67(8). https://doi.org/10.1093/ejcts/ezaf256
Vancouver
Kawashima M, Ijiri N, Konoeda C, Toyokawa G, Nakao K, Cong Y, et al. Extended Use of Central Veno-Arterial Extracorporeal Membrane Oxygenation in Lung Transplantation for Patients with Pulmonary Arterial Hypertension. European Journal of Cardio-Thoracic Surgery. 2025;67(8). doi:10.1093/ejcts/ezaf256
BibTeX
@article{Kawashima2025,
author = {Kawashima, Mitsuaki and Ijiri, Naohiro and Konoeda, Chihiro and Toyokawa, Gouji and Nakao, Keita and Cong, Yue and Hino, Haruaki and Kurosawa, Hideo and Kashiwa, Koichi and Ushio, Michiko and Kawamura, Gaku and Ando, Masahiko and Shimada, Shogo and Ono, Minoru and Sato, Masaaki},
title = {Extended Use of Central Veno-Arterial Extracorporeal Membrane Oxygenation in Lung Transplantation for Patients with Pulmonary Arterial Hypertension},
journal = {European Journal of Cardio-Thoracic Surgery},
year = {2025},
volume = {67},
number = {8},
doi = {10.1093/ejcts/ezaf256}
}
EUVIMED